(BusinessWeekly.co.uk) Quantum computing software specialist Riverlane is collaborating with Cambridge neighbour and world-leading fragment-based drug discovery company Astex to demonstrate the future potential of quantum chemistry.
Riverlane builds ground-breaking software to unleash the power of quantum computers. Chemistry is a key application in which quantum computing can be of significant value, as high-level quantum chemistry calculations can be solved far faster than using classical methods.
World leaders in drug discovery and development, Astex Pharmaceuticals apply innovative solutions to treat cancer and diseases of the central nervous system.
The two companies are combining their expertise in quantum computing software and quantum chemistry applications to speed up drug development and move us closer to quantum advantage.
As part of the collaboration, Astex is funding a post-doctoral research scientist at Riverlane. They will apply very high levels of quantum theory to study the properties of covalent drugs, in which protein function is blocked by the formation of a specific chemical bond.
Riverlane And Astex Pharmacuticals Combining Expertise in Quantum Computing Software & Quantum Chemistry to Speed Up Drug Development
